Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

7‑(3‑aminomethyl‑4‑substituted benzyloxyimino‑1‑pyrrolidinyl)naphthyridone carboxylic acids

A kind of methine dioxy, compound technology, applied in the field of medicinal chemistry

Inactive Publication Date: 2017-02-01
ZHEJIANG STARRY PHARMA +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But there is no substituent on the benzene ring in its benzyl

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 7‑(3‑aminomethyl‑4‑substituted benzyloxyimino‑1‑pyrrolidinyl)naphthyridone carboxylic acids
  • 7‑(3‑aminomethyl‑4‑substituted benzyloxyimino‑1‑pyrrolidinyl)naphthyridone carboxylic acids
  • 7‑(3‑aminomethyl‑4‑substituted benzyloxyimino‑1‑pyrrolidinyl)naphthyridone carboxylic acids

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 11

[0051] Example 11-[(1R,2S)-2-fluorocyclopropyl]-6-fluoro-7-[3-aminomethyl-4-(4-fluorobenzyloxyimino)-pyrrolidine-1- base]-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid

[0052] 1-[(1R,2S)-2-fluorocyclopropyl]-7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid (180mg , 0.6mmol), a mixture of 3-aminomethyl-4-(chlorobenzyloxyimino)-pyrrolidine dihydrochloride (345mg, 1mmol), triethylamine (0.42ml) and anhydrous acetonitrile (30ml) The reaction was stirred at room temperature for 10 h. Concentrate under reduced pressure, add 5% NaOH (5mL) to the residue, stir for 0.5h, filter with suction, adjust the pH of the filtrate to 6.5-7.0 with 20% acetic acid, and wash with CHCl 3 Extract and dry over anhydrous sodium sulfate. Filtration, the filtrate was concentrated under reduced pressure, the residue was slurried with ether-dichloromethane, and 230 mg of light yellow solid was filtered by suction, the yield (44.2%). (c 0.040, CH 3 OH), 1 H NMR (600MHz...

Embodiment 21-

[0059] Example 21-[(1R,2S)-2-fluorocyclopropyl]-6-fluoro-7-[3-aminomethyl-4-(4-chlorobenzyloxyimino)-pyrrolidine-1- base]-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid

[0060] Same as the preparation method of the compound in Example 1, 1-[(1R,2S)-2-fluorocyclopropyl]-7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8- Condensation reaction of naphthyridine-3-carboxylic acid with 3-aminomethyl-4-(4-chlorobenzyloxyimino)-pyrrolidine dihydrochloride, followed by alkaline hydrolysis to give a light white solid (53.9%) . (c 0.049, CH 3 OH), 1 H NMR(600MHz,dmso)δ8.67(s,1H),8.02(d,J=12.6Hz,1H),7.58–7.23(m,4H),5.25–4.99(m,3H),4.63(s, 2H),4.28–4.08(m,1H),3.92-3.89(m,1H),3.75-3.71(m,1H),3.02(s,1H),2.76-2.47(m,2H),1.91–1.79( m,1H),1.65-1.58(m,1H).MS-ESI(m / z):518.20(M+H) + .HRMS-ESI(m / z): Calcd.for C 18 h 20 o 4 N 5 f 2 (M+H) + :518.14011; Found: 518.14048.

Embodiment 31-

[0061] Example 31-[(1R,2S)-2-fluorocyclopropyl]-6-fluoro-7-[3-aminomethyl-4-(4-bromobenzyloxyimino)-pyrrolidine-1- base]-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid

[0062] Same as the preparation method of the compound in Example 1, 1-[(1R,2S)-2-fluorocyclopropyl]-7-chloro-6-fluoro-1,4-dihydro-4-oxo-1,8- Naphthyridine-3-carboxylic acid is condensed with 3-aminomethyl-4-(4-bromobenzyloxyimino)-pyrrolidine dihydrochloride, and then alkaline hydrolyzed to obtain a light white solid yield (33.7 %). (c 0.023, CH 3 OH), 1 H NMR (600MHz, dmso) δ8.67 (s, 1H), 8.01 (d, J = 12.6Hz, 1H), 7.60–7.50 (m, 2H), 7.33-7.29 (m, 2H), 5.26–5.01 ( m,3H),4.63(s,2H),4.29–4.05(m,1H),4.03–3.86(m,1H),3.75-3.71(dt,m,1H),3.01(s,1H),2.85– 2.67(m,2H),1.93–1.79(m,1H),1.71–1.56(m,1H).MS-ESI(m / z):562.12(M+H) + .HRMS-ESI(m / z): Calcd.for C 18 h 20 o 4 N 5 f 2 (M+H) + :562.09278; Found: 562.09326.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to 7-(3-aminomethyl-4-substituted-benzyloxyimino-1-pyrrolidinyl)naphthyridinone carboxylic acid compounds disclosed as Formula (I), a preparation method and medical application thereof, and an antituberculosis drug composition using the compounds as effective components, particularly, 6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridinyl-3-carboxylic acid compounds, wherein the 1- substituent group is (1R,2S)-2-fluorocyclopropyl group, the 7- substituent group is 3-aminomethyl-4-substituted-benzyloxyimino-1-pyrrolidinyl group, and R represents fluorine, chlorine, bromine, methyl, methoxy, dimethoxy or methynedioxy group.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and relates to 6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid compounds with anti-tuberculosis activity and a preparation method thereof, as well as compounds containing them The anti-tuberculosis pharmaceutical composition; More specifically, the 1-position substituting group of the naphthyridone carboxylic acid compounds involved in the present invention is (1R, 2S)-2-fluorocyclopropyl; 7-position substituting group is 3 -Aminomethyl-4-substituted benzyloxyimino-1-pyrrolidinyl. Background technique [0002] Tuberculosis (TB) is one of the major infectious diseases caused by Mycobacterium tuberculosis (MTB), which seriously endangers human health. Since the 1980s, the incidence of drug-resistant TB, especially multi-drug-resistant TB (MDR-TB), has been increasing and the combination of TB and HIV / AIDS has caused the TB epidemic to rise again, becoming a major public health pro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D471/04A61K31/4375A61P31/06
CPCC07D471/04
Inventor 刘明亮郭慧元黄举李林虎张芮王春兰沈伟艺陈仕洪
Owner ZHEJIANG STARRY PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com